29-year-old Gracie McGraw said Ozempic use in 2022 for PCOS symptoms brought back her eating disorder and negative body image, even though the drug helped her lose weight.
Instagram posts shared Monday said the rapid weight loss changed how people treated her — from friends and family to work — reinforcing what she called "skinny culture" and worsening disordered thinking.
McGraw said she later realized she had become "too skinny," now sees the treatment as one of the worst decisions for herself, and believes the medication permanently altered her internal system.
Her account echoes broader concerns from obesity specialists that GLP-1-driven weight loss can create psychological strain around identity, relationships and social routines, especially for people with prior eating-disorder risks.